Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones: what should therapists and patients expect.
Identifieur interne : 00B821 ( Ncbi/Curation ); précédent : 00B820; suivant : 00B822Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones: what should therapists and patients expect.
Auteurs : J R Casley-Smith [Australie] ; J R Casley-SmithSource :
- Lymphology [ 0024-7766 ] ; 1996.
Descripteurs français
- KwdFr :
- Administration par voie orale, Administration par voie topique, Anticoagulants (administration et posologie), Anticoagulants (usage thérapeutique), Association thérapeutique, Bras, Coumarines (administration et posologie), Coumarines (usage thérapeutique), Humains, Jambe, Lymphoedème (rééducation et réadaptation), Lymphoedème (traitement médicamenteux), O-(bêta-Hydroxyéthyl)rutosides (administration et posologie), O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique), Résultat thérapeutique, Techniques de physiothérapie.
- MESH :
- administration et posologie : Anticoagulants, Coumarines, O-(bêta-Hydroxyéthyl)rutosides.
- rééducation et réadaptation : Lymphoedème.
- traitement médicamenteux : Lymphoedème.
- usage thérapeutique : Anticoagulants, Coumarines, O-(bêta-Hydroxyéthyl)rutosides.
- Administration par voie orale, Administration par voie topique, Association thérapeutique, Bras, Humains, Jambe, Résultat thérapeutique, Techniques de physiothérapie.
English descriptors
- KwdEn :
- Administration, Oral, Administration, Topical, Anticoagulants (administration & dosage), Anticoagulants (therapeutic use), Arm, Combined Modality Therapy, Coumarins (administration & dosage), Coumarins (therapeutic use), Humans, Hydroxyethylrutoside (administration & dosage), Hydroxyethylrutoside (therapeutic use), Leg, Lymphedema (drug therapy), Lymphedema (rehabilitation), Physical Therapy Modalities, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Anticoagulants, Coumarins, Hydroxyethylrutoside.
- chemical , therapeutic use : Anticoagulants, Coumarins, Hydroxyethylrutoside.
- drug therapy : Lymphedema.
- rehabilitation : Lymphedema.
- Administration, Oral, Administration, Topical, Arm, Combined Modality Therapy, Humans, Leg, Physical Therapy Modalities, Treatment Outcome.
Abstract
Using previously presented data, from an open multi-centered trial, the Medians and Third Quartiles were calculated for the overall edema reductions the "average" patient received from an "average" therapist using Complex Physical Therapy (CPT) on 628 lymphedematous limbs. These data provide therapists and patients a general guideline as to the minimal reductions which can be expected in three quarters of patients from average therapists, using CPT with or without the administration of benzo-pyrones. Benzo-pyrones were considered separately: oral (given for three months before and for 11 months after the course of CPT) and topical (during and after CPT). Depending on which measure of edema and its alterations were used, these reductions increased those from CPT alone from 130% to 200% and, after one year, between 150% to 300%. Whereas the effects of oral and topical benzo-pyrones were not statistically different, their combined usage was more effective than use of either alone.
PubMed: 8823730
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005163
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :005163
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :005163
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :00B821
Links to Exploration step
pubmed:8823730Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones: what should therapists and patients expect.</title><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J R" last="Casley-Smith">J R Casley-Smith</name><affiliation wicri:level="1"><nlm:affiliation>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</wicri:regionArea><wicri:noRegion>University of Adelaide</wicri:noRegion></affiliation></author><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J R" last="Casley-Smith">J R Casley-Smith</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1996">1996</date><idno type="RBID">pubmed:8823730</idno><idno type="pmid">8823730</idno><idno type="wicri:Area/PubMed/Corpus">005163</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005163</idno><idno type="wicri:Area/PubMed/Curation">005163</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005163</idno><idno type="wicri:Area/PubMed/Checkpoint">005163</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005163</idno><idno type="wicri:Area/Ncbi/Merge">00B821</idno><idno type="wicri:Area/Ncbi/Curation">00B821</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones: what should therapists and patients expect.</title><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J R" last="Casley-Smith">J R Casley-Smith</name><affiliation wicri:level="1"><nlm:affiliation>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Henry Thomas Laboratory (Microcirculation Research), University of Adelaide</wicri:regionArea><wicri:noRegion>University of Adelaide</wicri:noRegion></affiliation></author><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J R" last="Casley-Smith">J R Casley-Smith</name></author></analytic><series><title level="j">Lymphology</title><idno type="ISSN">0024-7766</idno><imprint><date when="1996" type="published">1996</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term><term>Administration, Topical</term><term>Anticoagulants (administration & dosage)</term><term>Anticoagulants (therapeutic use)</term><term>Arm</term><term>Combined Modality Therapy</term><term>Coumarins (administration & dosage)</term><term>Coumarins (therapeutic use)</term><term>Humans</term><term>Hydroxyethylrutoside (administration & dosage)</term><term>Hydroxyethylrutoside (therapeutic use)</term><term>Leg</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (rehabilitation)</term><term>Physical Therapy Modalities</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie orale</term><term>Administration par voie topique</term><term>Anticoagulants (administration et posologie)</term><term>Anticoagulants (usage thérapeutique)</term><term>Association thérapeutique</term><term>Bras</term><term>Coumarines (administration et posologie)</term><term>Coumarines (usage thérapeutique)</term><term>Humains</term><term>Jambe</term><term>Lymphoedème (rééducation et réadaptation)</term><term>Lymphoedème (traitement médicamenteux)</term><term>O-(bêta-Hydroxyéthyl)rutosides (administration et posologie)</term><term>O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique)</term><term>Résultat thérapeutique</term><term>Techniques de physiothérapie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anticoagulants</term><term>Coumarins</term><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticoagulants</term><term>Coumarins</term><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anticoagulants</term><term>Coumarines</term><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticoagulants</term><term>Coumarines</term><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Administration, Topical</term><term>Arm</term><term>Combined Modality Therapy</term><term>Humans</term><term>Leg</term><term>Physical Therapy Modalities</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie orale</term><term>Administration par voie topique</term><term>Association thérapeutique</term><term>Bras</term><term>Humains</term><term>Jambe</term><term>Résultat thérapeutique</term><term>Techniques de physiothérapie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Using previously presented data, from an open multi-centered trial, the Medians and Third Quartiles were calculated for the overall edema reductions the "average" patient received from an "average" therapist using Complex Physical Therapy (CPT) on 628 lymphedematous limbs. These data provide therapists and patients a general guideline as to the minimal reductions which can be expected in three quarters of patients from average therapists, using CPT with or without the administration of benzo-pyrones. Benzo-pyrones were considered separately: oral (given for three months before and for 11 months after the course of CPT) and topical (during and after CPT). Depending on which measure of edema and its alterations were used, these reductions increased those from CPT alone from 130% to 200% and, after one year, between 150% to 300%. Whereas the effects of oral and topical benzo-pyrones were not statistically different, their combined usage was more effective than use of either alone.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B821 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 00B821 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:8823730
|texte= Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones: what should therapists and patients expect.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:8823730" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |